id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0500-0006,FDA,FDA-2013-N-0500,Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products; Correction and Extension of Comment Period,Proposed Rule,Extension of Comment Period,2013-12-27T05:00:00Z,2013,12,2013-12-27T05:00:00Z,2014-03-14T03:59:59Z,2014-04-10T01:02:03Z,2013-30881,0,0,09000064814debad
FDA-2013-N-0500-0005,FDA,FDA-2013-N-0500,"OMB Review Proposed Rule re Executive Order 12866, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products 11-13-2013 - Memorandum",Other,Memorandum,2013-12-13T05:00:00Z,2013,12,2013-12-13T05:00:00Z,,2013-12-13T16:08:47Z,,0,0,09000064814bc8a9
FDA-2013-N-0500-0004,FDA,FDA-2013-N-0500,Generic Pharmaceutical Association (GPhA) - Request for Extension of Comment Period,Other,Request for Extension,2013-12-04T05:00:00Z,2013,12,2013-12-04T05:00:00Z,,2013-12-04T20:09:50Z,,0,0,090000648149a218
FDA-2013-N-0500-0002,FDA,FDA-2013-N-0500,"OMB Review Proposed Rule re Executive Order 12866, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products 11-13-2013 - Memorandum",Other,,2013-11-21T00:00:00Z,2013,11,,,2013-11-25T14:34:53Z,,0,1,090000648148e9e1
FDA-2013-N-0500-0001,FDA,FDA-2013-N-0500,Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2013-11-13T05:00:00Z,2013,11,2013-11-13T05:00:00Z,2014-01-14T04:59:59Z,2016-04-26T19:00:32Z,2013-26799,0,0,090000648147a982